Welcome to LookChem.com Sign In|Join Free

CAS

  • or

87808-49-9

Post Buying Request

87808-49-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

87808-49-9 Usage

Chemical Properties

off-white powder

Check Digit Verification of cas no

The CAS Registry Mumber 87808-49-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,7,8,0 and 8 respectively; the second part has 2 digits, 4 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 87808-49:
(7*8)+(6*7)+(5*8)+(4*0)+(3*8)+(2*4)+(1*9)=179
179 % 10 = 9
So 87808-49-9 is a valid CAS Registry Number.
InChI:InChI=1/C9H9BrO2/c1-6-3-4-7(8(10)5-6)9(11)12-2/h3-5H,1-2H3

87808-49-9 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (H63144)  Methyl 2-bromo-4-methylbenzoate, 98%   

  • 87808-49-9

  • 250mg

  • 255.0CNY

  • Detail
  • Alfa Aesar

  • (H63144)  Methyl 2-bromo-4-methylbenzoate, 98%   

  • 87808-49-9

  • 1g

  • 764.0CNY

  • Detail
  • Alfa Aesar

  • (H63144)  Methyl 2-bromo-4-methylbenzoate, 98%   

  • 87808-49-9

  • 5g

  • 3058.0CNY

  • Detail

87808-49-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name Methyl 2-bromo-4-methylbenzoate

1.2 Other means of identification

Product number -
Other names methyl 2-bromo-4-methylbenzoate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:87808-49-9 SDS

87808-49-9Relevant articles and documents

HDAC7 Inhibition by Phenacetyl and Phenylbenzoyl Hydroxamates

Mak, Jeffrey Y. W.,Wu, Kai-Chen,Gupta, Praveer K.,Barbero, Sheila,McLaughlin, Maddison G.,Lucke, Andrew J.,Tng, Jiahui,Lim, Junxian,Loh, Zhixuan,Sweet, Matthew J.,Reid, Robert C.,Liu, Ligong,Fairlie, David P.

, p. 2186 - 2204 (2021/03/01)

The zinc-containing histone deacetylase enzyme HDAC7 is emerging as an important regulator of immunometabolism and cancer. Here, we exploit a cavity in HDAC7, filled by Tyr303 in HDAC1, to derive new inhibitors. Phenacetyl hydroxamates and 2-phenylbenzoyl hydroxamates bind to Zn2+ and are 50-2700-fold more selective inhibitors of HDAC7 than HDAC1. Phenylbenzoyl hydroxamates are 30-70-fold more potent HDAC7 inhibitors than phenacetyl hydroxamates, which is attributed to the benzoyl aromatic group interacting with Phe679 and Phe738. Phthalimide capping groups, including a saccharin analogue, decrease rotational freedom and provide hydrogen bond acceptor carbonyl/sulfonamide oxygens that increase inhibitor potency, liver microsome stability, solubility, and cell activity. Despite being the most potent HDAC7 inhibitors to date, they are not selective among class IIa enzymes. These strategies may help to produce tools for interrogating HDAC7 biology related to its catalytic site.

A hit deconstruction approach for the discovery of fetal hemoglobin inducers

Benowitz, Andrew B.,Eberl, H. Christian,Erickson-Miller, Connie L.,Gilmartin, Aidan G.,Gore, Elizabeth R.,Montoute, Monica N.,Wu, Zining

supporting information, p. 3676 - 3680 (2018/10/31)

Beta-hemoglobinopathies such as sickle cell disease represent a major global unmet medical need. De-repression of fetal hemoglobin in erythrocytes is a clinically validated approach for the management of sickle cell disease, but the only FDA-approved medicine for this purpose has limitations to its use. We conducted a phenotypic screen in human erythroid progenitor cells to identify molecules with the ability to de-repress fetal hemoglobin, which resulted in the identification of the benzoxaborole-containing hit compound 1. This compound was found to have modest cellular potency and lead-like pharmacokinetics, but no identifiable SAR to enable optimization. Systematic deconstruction of a closely related analog of 1 revealed the fragment-like carboxylic acid 12, which was then optimized to provide tetrazole 31, which had approximately 100-fold improved cellular potency compared to 1, high levels of oral exposure in rats, and excellent solubility.

Pharmaceutical compositions (by machine translation)

-

Paragraph 0174, (2019/01/31)

[Problem] imidazole compound or its pharmacologically acceptable salt in the melanocortin receptor activity that operates as an active ingredient of a pharmaceutical composition comprising. "I" general formula [a]" Formula, the aryl group may be substituted A ring represents a; R1 Represents a hydrogen atom, or an alkyl group which may be substituted represented; R2 Represents a hydrogen atom, a halogen atom or represents a; R3 The alkyl group may be substituted " represented by the imidazole compound, its pharmacologically acceptable salt as an active ingredient in a pharmaceutical composition. [Drawing] no (by machine translation)

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 87808-49-9